IP Library › Granted Patent US 8,026,072
Granted Patent B2
US 8,026,072 · App. 12/715,987 · Granted Sep 27, 2011

Method of identifying compounds that bind BAFF-R

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,072
App. No.
12/715,987
Granted
Sep 27, 2011
Kind
B2
Abstract

Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to BAFF-R polypeptides and pharmaceutical compositions including the same. Methods of treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides, antibodies and pharmaceutical compositions of this invention are also provided.

Claims (3)

1. A method for identifying a compound that binds to BAFF-R comprising:

(a) contacting BAFF-R with a compound;

(b) determining whether the compound binds to BAFF-R.

Assignments (1)
CHANGE OF NAME Recorded May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →